Clinical Trial Update: The Effects of Nanomicelles Curcumin on Glycemic Control, Serum Lipid Profile ,Blood Pressure and Anthropometric Measurements in Patients With Metabolic Syndrome [NA]

View source ↗

Summary

A clinical trial update evaluating the effects of a nanomicelles formulation of curcumin on glycemic control, lipid profile, blood pressure, and anthropometric …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Nanomicelles Curcumin (curcumin nanomicellar formulation)

Snippet

Sponsor: National Nutrition and Food Technology Institute | Conditions: Metabolic Syndrome | NA | Status: UNKNOWN